These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
114 related articles for article (PubMed ID: 29108920)
1. Correlation of lysosome-associated protein transmembrane-4β gene overexpression with the malignant phenotypes of hepatocellular carcinoma. Su H; Xu T; Huang X; Zang S; Wang B; Huang Y; Liu J; Huang A Pathol Res Pract; 2017 Dec; 213(12):1536-1541. PubMed ID: 29108920 [TBL] [Abstract][Full Text] [Related]
2. Expression of lysosome-associated protein transmembrane 4B-35 in cancer and its correlation with the differentiation status of hepatocellular carcinoma. Peng C; Zhou RL; Shao GZ; Rui JA; Wang SB; Lin M; Zhang S; Gao ZF World J Gastroenterol; 2005 May; 11(18):2704-8. PubMed ID: 15884107 [TBL] [Abstract][Full Text] [Related]
3. LAPTM4B-35 overexpression is a risk factor for tumor recurrence and poor prognosis in hepatocellular carcinoma. Yang H; Xiong FX; Lin M; Yang Y; Nie X; Zhou RL J Cancer Res Clin Oncol; 2010 Feb; 136(2):275-81. PubMed ID: 19690886 [TBL] [Abstract][Full Text] [Related]
4. Structure analysis and expressions of a novel tetratransmembrane protein, lysosoma-associated protein transmembrane 4 beta associated with hepatocellular carcinoma. Liu XR; Zhou RL; Zhang QY; Zhang Y; Jin YY; Lin M; Rui JA; Ye DX World J Gastroenterol; 2004 Jun; 10(11):1555-9. PubMed ID: 15162524 [TBL] [Abstract][Full Text] [Related]
5. Expression signature of lysosomal-associated transmembrane protein 4B in hepatitis C virus-induced hepatocellular carcinoma. Roy G; Roy P; Bhattacharjee A; Shahid M; Misbah M; Gupta S; Husain M Int J Biol Markers; 2018 Aug; 33(3):283-292. PubMed ID: 29882487 [TBL] [Abstract][Full Text] [Related]
6. Molecular cloning and characterization of LAPTM4B, a novel gene upregulated in hepatocellular carcinoma. Shao GZ; Zhou RL; Zhang QY; Zhang Y; Liu JJ; Rui JA; Wei X; Ye DX Oncogene; 2003 Aug; 22(32):5060-9. PubMed ID: 12902989 [TBL] [Abstract][Full Text] [Related]
7. Upregulation of LAPTM4B-35 promotes malignant transformation and tumorigenesis in L02 human liver cell line. Li L; Shan Y; Yang H; Zhang S; Lin M; Zhu P; Chen XY; Yi J; McNutt MA; Shao GZ; Zhou RL Anat Rec (Hoboken); 2011 Jul; 294(7):1135-42. PubMed ID: 21618708 [TBL] [Abstract][Full Text] [Related]
8. Overexpression of LAPTM4B-35 promotes growth and metastasis of hepatocellular carcinoma in vitro and in vivo. Yang H; Xiong F; Wei X; Yang Y; McNutt MA; Zhou R Cancer Lett; 2010 Aug; 294(2):236-44. PubMed ID: 20202745 [TBL] [Abstract][Full Text] [Related]
9. LAPTM4B-35 is a novel prognostic factor of hepatocellular carcinoma. Yang H; Xiong F; Qi R; Liu Z; Lin M; Rui J; Su J; Zhou R J Surg Oncol; 2010 Apr; 101(5):363-9. PubMed ID: 20358632 [TBL] [Abstract][Full Text] [Related]
10. AP4 positively regulates LAPTM4B to promote hepatocellular carcinoma growth and metastasis, while reducing chemotherapy sensitivity. Meng Y; Wang L; Xu J; Zhang Q Mol Oncol; 2018 Mar; 12(3):373-390. PubMed ID: 29337428 [TBL] [Abstract][Full Text] [Related]
11. Combined lysosomal protein transmembrane 4 beta-35 and argininosuccinate synthetase expression predicts clinical outcome in hepatocellular carcinoma patients. Yang H; Lin M; Xiong F; Yang Y; Nie X; McNutt MA; Zhou R Surg Today; 2011 Jun; 41(6):810-7. PubMed ID: 21626328 [TBL] [Abstract][Full Text] [Related]
12. HDAC2 promotes autophagy-associated HCC malignant progression by transcriptionally activating LAPTM4B. Wang M; Liao J; Wang J; Xu M; Cheng Y; Wei L; Huang A Cell Death Dis; 2024 Aug; 15(8):593. PubMed ID: 39147759 [TBL] [Abstract][Full Text] [Related]
13. Noninvasively visualize the expression of LAPTM4B protein using a novel Ren Y; Hu K; Bi L; Wu H; Li Y; Han Y; Zhou W; Li H; Jin H; Wu H Nucl Med Biol; 2021; 100-101():52-60. PubMed ID: 34214768 [TBL] [Abstract][Full Text] [Related]
14. LAPTM4B-35, a novel tetratransmembrane protein and its PPRP motif play critical roles in proliferation and metastatic potential of hepatocellular carcinoma cells. Liu X; Xiong F; Wei X; Yang H; Zhou R Cancer Sci; 2009 Dec; 100(12):2335-40. PubMed ID: 19843073 [TBL] [Abstract][Full Text] [Related]
15. [Identification and characterization of LAPTM4B encoded by a human hepatocellular carcinoma-associated novel gene]. Liu X; Zhou R; Zhang Q; Zhang Y; Shao G; Jin Y; Zhang S; Lin M; Rui J; Ye D Beijing Da Xue Xue Bao Yi Xue Ban; 2003 Aug; 35(4):340-7. PubMed ID: 12947545 [TBL] [Abstract][Full Text] [Related]
16. LAPTM4B-35, a cancer-related gene, is associated with poor prognosis in TNM stages I-III gastric cancer patients. Cheng X; Zheng Z; Bu Z; Wu X; Zhang L; Xing X; Wang X; Hu Y; Du H; Li L; Li S; Zhou R; Wen XZ; Ji JF PLoS One; 2015; 10(4):e0121559. PubMed ID: 25849595 [TBL] [Abstract][Full Text] [Related]
17. Elevated lysosome-associated protein transmembrane-4β-35 is an independent prognostic marker in pancreatic carcinoma. Zhang G; Liang Y; Huang Y; Chen Y; Zhou R J Int Med Res; 2012; 40(4):1275-83. PubMed ID: 22971479 [TBL] [Abstract][Full Text] [Related]
18. The human LAPTM4b transcript is upregulated in various types of solid tumours and seems to play a dual functional role during tumour progression. Kasper G; Vogel A; Klaman I; Gröne J; Petersen I; Weber B; Castaños-Vélez E; Staub E; Mennerich D Cancer Lett; 2005 Jun; 224(1):93-103. PubMed ID: 15911104 [TBL] [Abstract][Full Text] [Related]
19. Upregulated FoxM1 expression induced by hepatitis B virus X protein promotes tumor metastasis and indicates poor prognosis in hepatitis B virus-related hepatocellular carcinoma. Xia L; Huang W; Tian D; Zhu H; Zhang Y; Hu H; Fan D; Nie Y; Wu K J Hepatol; 2012 Sep; 57(3):600-12. PubMed ID: 22613004 [TBL] [Abstract][Full Text] [Related]
20. Overexpression of WWP1 promotes tumorigenesis and predicts unfavorable prognosis in patients with hepatocellular carcinoma. Zhang XF; Chao J; Pan QZ; Pan K; Weng DS; Wang QJ; Zhao JJ; He J; Liu Q; Jiang SS; Chen CL; Zhang HX; Xia JC Oncotarget; 2015 Dec; 6(38):40920-33. PubMed ID: 26506518 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]